Growth Metrics

Nexalin Technology (NXL) Shares Outstanding (Weighted Average) (2021 - 2026)

Nexalin Technology's quarterly Shares Outstanding (Weighted Average) came in at $19.8 million in Q1 2026, up 644.52% year-on-year from $2.7 million in Q1 2025, and up 20.91% quarter-over-quarter from $16.4 million in Q4 2025.

Nexalin Technology has reported Shares Outstanding (Weighted Average) for 6 years, with the latest figure at $19.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 644.52% year-over-year to $19.8 million; the trailing twelve-month figure through Mar 2026 stood at $19.8 million (up 644.52% YoY), and the FY2025 full-year result was $16.4 million, up 515.74% from the prior year.
  • Shares Outstanding (Weighted Average) for Q1 2026 stood at $19.8 million, up from $16.4 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $19.8 million in Q1 2026, with the low at $2.7 million in Q2 2023.
  • Average Shares Outstanding (Weighted Average) over 5 years is $7.4 million, with a median of $5.6 million recorded in 2022.
  • Year-over-year, Shares Outstanding (Weighted Average) jumped 25698.16% in 2022 and tumbled 64.35% in 2025.
  • Tracing NXL's Shares Outstanding (Weighted Average) over 5 years: stood at $5.6 million in 2022, then jumped by 32.03% to $7.4 million in 2023, then slumped by 63.81% to $2.7 million in 2024, then jumped by 515.74% to $16.4 million in 2025, then increased by 20.91% to $19.8 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $19.8 million (Q1 2026), $16.4 million (Q4 2025), and $15.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.74 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 382.90 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.28 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.48 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 579.20 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 385.10 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 456.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 98.20 Mn
10 Nexalin Technology 11.19 Mn 8.48 Mn 13,133.00 19.82 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 19.82 Mn
Dec 31, 2025 16.39 Mn
Sep 30, 2025 15.63 Mn
Jun 30, 2025 2.66 Mn
Mar 31, 2025 2.66 Mn
Dec 31, 2024 2.66 Mn
Sep 30, 2024 10.85 Mn
Jun 30, 2024 7.47 Mn
Mar 31, 2024 2.66 Mn
Dec 31, 2023 7.36 Mn
Sep 30, 2023 7.42 Mn
Jun 30, 2023 2.66 Mn
Mar 31, 2023 7.29 Mn
Dec 31, 2022 5.57 Mn
Sep 30, 2022 5.19 Mn
Jun 30, 2022 4.90 Mn
Mar 31, 2022 4.91 Mn
Dec 31, 2021 21,600.00
Sep 30, 2021 4.50 Mn